Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 1980 Oct;10 Suppl 2(Suppl 2):299S-308S.
doi: 10.1111/j.1365-2125.1980.tb01813.x.

Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone)

Review

Kinetics and metabolism of pyrazolones (propyphenazone, aminopyrine and dipyrone)

M Volz et al. Br J Clin Pharmacol. 1980 Oct.

Abstract

1 Propyphenazone 220 mg was administered orally to volunteers. Maximum plasma concentrations between 1.5 microgram/ml and 3.5 micrograms/ml were found 30 min later. After comparable doses plasma concentrations in dog and rabbit were lower. The distribution volumes were 2 l/kg. 2 The major metabolic route of propyphenazone is demethylation. The main urinary metabolite is the enolglucuronide of N-(2)-demethylpropyphenazone. 3 Aminopyrine is rapidly and almost completely absorbed after oral administration. Maximum plasma concentrations of 10 microgram/ml are reached 1.5 h after a 500 mg dose. The biological half-life is 2-3 h, the relative distribution volume 60% on average, and binding to plasma proteins approximately 15%. 4 Unchanged aminopyrine is only excreted in small quantities. The major routes of metabolism are demethylation (4-methylaminoantipyrine and 4-aminoantipyrine) and acylation (4-acetyl and 4-formylaminoantipyrine). There are other biotransformation products. 5 After oral administration of [14C]-dipyrone 480 mg the maximum serum concentration of 13.4 +/- 0.8 microgram/ml occurred at 1-1.5 hours. 6 Dipyrone was not detectable in serum or urine. Four of seven metabolites were identified, and were identical with the main metabolites of aminopyrine.

PubMed Disclaimer

References

    1. Arzneimittelforschung. 1965 Jul;15(7):741-7 - PubMed
    1. Arch Int Pharmacodyn Ther. 1969 Aug;180(2):309-22 - PubMed
    1. Yakugaku Zasshi. 1970 Mar;90(3):378-83 - PubMed
    1. Yakugaku Zasshi. 1970 Nov;90(11):1406-11 - PubMed
    1. Klin Wochenschr. 1972 Dec 1;50(23):1092-6 - PubMed

LinkOut - more resources